{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:07:16Z","timestamp":1765278436090,"version":"3.46.0"},"reference-count":54,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Anal canal squamous cell cancer (ASCC) is commonly treated with chemoradiotherapy (CRT). Inflammatory bowel disease (IBD) is a relative contraindication to pelvic radiotherapy due to toxicity concerns. Advances in treatment planning since the 2000s have resulted in lower radiation doses delivered to nearby at-risk organs. We systematically reviewed the literature to answer the question \u201cDo IBD patients with ASCC treated with CRT have different outcomes than non-IBD patients in the present era?\u201d. We searched the Medline, Web of Science, Cochrane, ClinicalTrials.gov, and CINAHL databases for English-language articles published between 1 January 2001 and 1 January 2025. We included patients with ASCC treated curatively with CRT. This systematic review is registered in the PROSPERO international systematic review registry (CRD420251062114). A total of 220 unique articles were identified. Two reviewers independently screened titles and abstracts, which was followed by full-text screening. Eleven publications, comprising 24 patients, were included in the systematic review. The local recurrence rate following CRT was 25%, and 30% of patients had documented late toxicity. The included literature consists of case reports and small case series. Despite the limitations, our review shows toxicity, local control, and survival outcomes for IBD patients with ASCC treated with CRT that are comparable to those of non-IBD patients.<\/jats:p>","DOI":"10.3390\/curroncol32120693","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T09:54:55Z","timestamp":1765274095000},"page":"693","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of Anal Cancer Patients with Inflammatory Bowel Disease Treated with Curative Chemoradiotherapy: A Systematic Review of Current Evidence"],"prefix":"10.3390","volume":"32","author":[{"given":"Benjamin","family":"Royal-Preyra","sequence":"first","affiliation":[{"name":"Master of Cancer Sciences Program, University of Melbourne, Melbourne, VIC 3010, Australia"},{"name":"Department of Radiation Oncology, Centre Hospitalier Affili\u00e9 Universitaire R\u00e9gional, Trois-Rivieres, QC G8Z 3R9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1795-8554","authenticated-orcid":false,"given":"Melanie","family":"Boucher","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Centre Hospitalier Affili\u00e9 Universitaire R\u00e9gional, Trois-Rivieres, QC G8Z 3R9, Canada"},{"name":"Specialized Nurse Practitioner Program-Adult Health (IPSSA), Faculty of Nursing, Universit\u00e9 Laval, Quebec City, QC G1V 0A6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/CEJ.0000000000000842","article-title":"Global trends in anal cancer incidence and mortality","volume":"33","author":"Mignozzi","year":"2024","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3390\/curroncol30030246","article-title":"Anal Cancer: The Past, Present and Future","volume":"30","author":"Gondal","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.14309\/ajg.0000000000002503","article-title":"Monitoring Patients With Inflammatory Bowel Disease at High Risk of Anal Cancer","volume":"119","author":"Cairns","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","article-title":"Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer","volume":"386","author":"Palefsky","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_5","first-page":"183","article-title":"Current treatment and future directions in the management of anal cancer","volume":"72","author":"Tchelebi","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: A preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis. Colon Rectum"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L","article-title":"Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal","volume":"51","author":"Nigro","year":"1983","journal-title":"Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(85)90428-0","article-title":"Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy","volume":"78","author":"Leichman","year":"1985","journal-title":"Am. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"UKCCCR Anal Cancer Trial Working Party, and UK Co-ordinating Committee on Cancer Research (1996). Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet, 348, 1049\u20131054.","DOI":"10.1016\/S0140-6736(96)03409-5"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","article-title":"Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups","volume":"15","author":"Bartelink","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): A randomised, phase 3, open-label, 2 \u00d7 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: Final analysis of the randomized UNICANCER ACCORD 03 trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.6004\/jnccn.2023.0030","article-title":"Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Benson","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: Pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.suc.2019.08.001","article-title":"Inflammatory Bowel Disease Presentation and Diagnosis","volume":"99","author":"Flynn","year":"2019","journal-title":"Surg. Clin. N. Am."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ueg2.12319","article-title":"Environmental risk factors for inflammatory bowel disease","volume":"10","author":"Singh","year":"2022","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7247238","DOI":"10.1155\/2019\/7247238","article-title":"A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease","volume":"2019","author":"Guan","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/jcag\/gwad004","article-title":"The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD","volume":"6","author":"Coward","year":"2023","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cai, Z., Wang, S., and Li, J. (2021). Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front. Med., 8.","DOI":"10.3389\/fmed.2021.765474"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.gtc.2022.05.003","article-title":"Cancer in Inflammatory Bowel Disease","volume":"51","author":"Faye","year":"2022","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/ecco-jcc\/jjad045","article-title":"Anal High-risk Human Papillomavirus Infection, Squamous Intraepithelial Lesions, and Anal Cancer in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"17","author":"Albuquerque","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.21037\/jgo-22-138","article-title":"Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: A scoping review","volume":"13","author":"Bodofsky","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1017\/S1460396920000783","article-title":"Should inflammatory bowel disease be a contraindication to radiation therapy: A systematic review of acute and late toxicities","volume":"20","author":"Cantrell","year":"2020","journal-title":"J. Radiother. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","article-title":"Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(\u2606)","volume":"32","author":"Rao","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1102\/1470-7330.2004.0003","article-title":"Intensity-modulated radiotherapy\u2014What is it?","volume":"4","author":"Taylor","year":"2004","journal-title":"Cancer Imaging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1259\/bjr\/22373346","article-title":"Volumetric modulated arc therapy: A review of current literature and clinical use in practice","volume":"84","author":"Teoh","year":"2011","journal-title":"Br. J. Radiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"420","DOI":"10.5195\/jmla.2018.345","article-title":"The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: A systematic review","volume":"106","author":"Eriksen","year":"2018","journal-title":"J. Med. Libr. Assoc."},{"key":"ref_31","first-page":"2127","article-title":"Methodological quality of case series studies: An introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"102939","DOI":"10.1016\/j.eclinm.2024.102939","article-title":"International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): Defining the outcomes from the CORMAC core outcome set","volume":"78","author":"Samuel","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4097\/kjae.2013.64.5.402","article-title":"The prevention and handling of the missing data","volume":"64","author":"Kang","year":"2013","journal-title":"Korean J. Anesthesiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s10350-004-0864-9","article-title":"Squamous-cell carcinoma developing after an ileoanal pouch procedure: Report of a case","volume":"48","author":"Schaffzin","year":"2005","journal-title":"Dis. Colon Rectum"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/DCR.0b013e318197d0ad","article-title":"Cancer of the anus complicating perianal Crohn\u2019s disease","volume":"52","author":"Devon","year":"2009","journal-title":"Dis. Colon Rectum"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1463-1318.2009.02124.x","article-title":"Squamous cell carcinoma of an ileo-anal pouch","volume":"12","author":"Macdonald","year":"2010","journal-title":"Color. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/DCR.0000000000000700","article-title":"Fistula-Associated Anorectal Cancer in the Setting of Crohn\u2019s Disease","volume":"59","author":"Shwaartz","year":"2016","journal-title":"Dis. Colon Rectum"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00384-017-2794-8","article-title":"Long-standing Crohn\u2019s disease and its implication on anal squamous cell cancer management","volume":"32","author":"Lightner","year":"2017","journal-title":"Int. J. Color. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000455898","article-title":"Squamous Cell Carcinoma of the Anal Transitional Zone after Ileal Pouch Surgery for Ulcerative Colitis: Systematic Review and Treatment Perspectives","volume":"10","author":"Pellino","year":"2017","journal-title":"Case Rep. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/8756479318769238","article-title":"Transperineal Sonography of Anal Mass Status Post Total Colectomy: A Case Report","volume":"34","author":"Rohrbach","year":"2018","journal-title":"J. Diagn. Med. Sonogr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000501121","article-title":"Subcutaneous Magnesium Sulfate to Correct High-Output Ileostomy-Induced Hypomagnesemia","volume":"13","author":"Makowsky","year":"2019","journal-title":"Case Rep. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1007\/s10620-020-06130-8","article-title":"A Failure to Communicate: Disentangling the Causes of Perianal Fistul\u00e6 in Crohn\u2019s Disease and Anal Squamous Cell Cancer","volume":"65","author":"Weingarden","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s13691-021-00497-9","article-title":"Chemoradiotherapy for fistula-related perianal squamous cell carcinoma with Crohn\u2019s disease","volume":"10","author":"Sakanaka","year":"2021","journal-title":"Int. Cancer Conf. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/DCR.0000000000002011","article-title":"Anal Squamous Cell Carcinoma in Ulcerative Colitis: Can Pouches Withstand Traditional Treatment Protocols?","volume":"64","author":"Lightner","year":"2021","journal-title":"Dis. Colon Rectum"},{"key":"ref_45","unstructured":"Joanna Briggs, I. (2025, May 01). JBI Levels of Evidence. Available online: https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI-Levels-of-evidence_2014_0.pdf."},{"key":"ref_46","first-page":"217","article-title":"Chapter 7: Systematic Reviews of Etiology and Risk","volume":"1","author":"Moola","year":"2020","journal-title":"JBI Man. Evid. Synth."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnci\/djz219","article-title":"Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001\u20132015","volume":"112","author":"Deshmukh","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_49","unstructured":"American Cancer Society (2023). Anal Cancer Survival Rates, American Cancer Society."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Laredo, V., Garc\u00eda-Mateo, S., Mart\u00ednez-Dom\u00ednguez, S.J., de la Cruz, J.L., Gargallo-Puyuelo, C.J., and Gomoll\u00f3n, F. (2023). Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management. Cancers, 15.","DOI":"10.3390\/cancers15030871"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/GRF.0000000000000789","article-title":"Anal Cancer and Anal Cancer Screening","volume":"66","author":"Cohen","year":"2023","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/ecco-jcc\/jjx035","article-title":"Anal Neoplasia in Inflammatory Bowel Disease: Classification Proposal, Epidemiology, Carcinogenesis, and Risk Management Perspectives","volume":"11","author":"Wisniewski","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid.-Based Med."},{"key":"ref_54","unstructured":"Popovic, A., and Huecker, M.R. (2025). Study Bias. StatPearls, StatPearls Publishing."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/12\/693\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:02:47Z","timestamp":1765278167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/12\/693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["curroncol32120693"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32120693","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]}}}